Member Info for volcano

John Walden, Chief Executive of Home Retail Group, commented: "We are pleased to have delivered another full-year of like-for-like sales growth in both Argos and Homebase. Although our sales performance was weaker in the final short trading period, we managed the business effectively during this period and achieved a good performance in both gross margin and costs. As a result of this, we expect that Group benchmark profit before tax for the FY15 financial year will be towards the top end of the current range of market expectations of £120m to £132m.

Apr 29, 2015 Full Year 2014/2015 Home Retail Group PLC Earnings Release - 2:00am GMT-4 - Add to calendar

i have bought FXPO at 55p, 65p and 75p against the brokers advice ,see what happens .

up and away

Description JQW plc operates a business to business (B2B) e-commerce platform focused on connecting Chinese buyers with Chinese sellers. This platform is operated through the domain www.jqw.com. The Company specifically targets small and medium-sized domestic businesses providing Chinese Small and medium enterprises (SMEs) with a range of services and an ability to connect and advertise their products to potential buyers through the Internet. Services provided by www.jqw.com include Website design, commercial search services, advertising and the supply of business information and opportunities. Websites created for both free members and fee-paying members and their products are uploaded on to the relevant industry section of www.jqw.com appropriate to the product, where they can be accessed through the www.jqw.com home page. Buyers are provided access to the Websites and products of the Company’s free and fee-paying member's.

£80m turnover £22m profits and dissent dividend to go with it ,over £1 for me.

no problem - soon

Pre-Close Trading Update Mon, 16th Feb 2015 07:00 RNS Number : 9410E JQW PLC 16 February 2015 ? Press Release 16 February 2015 JQW plc ("JQW", the "Group" or the "Company") Pre-Close Trading Update Notice of Preliminary Results JQW plc, a domestic Chinese B2B e-commerce operator, provides the following trading update as the Group enters its close period. The Board confirms that revenues for the period were ahead of market expectations, with unaudited management accounts showing revenues reaching approximately RMB 784 million (2013: RMB 490 million). Profits for the period were in line with expectations and profit before tax for the period has increased to around RMB 212 million (2013: RMB 170 million) (exchange rate: RMB 9.6 : £1). Consistent with recent trends, our distribution mix has seen a further rise in the sales agencies channel, as opposed to our own sales force channel, from 78% of revenues in 2013 to 88% in 2014. This has translated into higher cost of sales as a result of commissions paid to agents. Similarly, our client base has continued to trade up to more expensive packages, which provide them with advertorial services through other media channels. The cost for JQW to purchase advertising rights on different media channels to support the advertorial services rose from RMB 10 million in 2013 to around RMB 58 million in 2014. This has also translated into a decline in gross margin. As at 31 December 2014, the Group had 241,000 active fee paying members which compares to 221,000 at the end of June 2014 and 197,000 at the end of December 2013. JQW remains highly cash generative and the Group maintains its strong balance sheet with cash as at 31 December 2014 amounting to RMB 395 million (2013: RMB 344 million). This robust cash position, which is after the Group paid an interim and special dividend to shareholders totalling RMB 101.6 million in October 2014, is equal to 21.3 pence per share or 195% of the Group's market capitalisation as at 13 February 2015. Yongde Cai, Chairman of JQW, said: "The Board is extremely pleased with the solid progress that the Group has made throughout 2014. Trading in the new financial year has started positively and we are close to finalising the development of our platforms for smartphone users which will further broaden our offering and take advantage of the rapidly growing Chinese B2B e-commerce market. "As expected in such a fast growth marketplace, we are beginning to witness some increased pricing competition from other B2B platforms in China. JQW's management team anticipated this market evolution and have already initiated a focused marketing strategy as well as a review of the packages that we offer our customers in order to maintain our competitive advantage. "JQW remains committed to its AIM listing and the Board believes that JQW c

the trading volumes are very high today ,Monday will be even better .

it is up more than 30% since come on the market .

i like what i see here

lots of buying going on today ,looking better and better

steady buying today

next stop is £ 22.55

soon we will get there

next stop 180p

EMG is been claiming in a strait line nearly for a year ,great.

Panmure Gordon reiterated their buy rating on shares of Bank of Georgia Holdings PLC (LON:BGEO) in a research note released on Thursday morning. They currently have a GBX 2,400 ($35.70) target price on the stock. Shares of Bank of Georgia Holdings PLC (LON:BGEO) opened at 1802.00 on Thursday. Bank of Georgia Holdings PLC has a 1-year low of GBX 1675.00 and a 1-year high of GBX 2766.62. The stock’s 50-day moving average is GBX 1867. and its 200-day moving average is GBX 2129.. The company’s market cap is £684.36 million. Bank of Georgia Holdings plc (LON:BGEO) is a holding company for JSC Bank of Georgia (the Bank). BGH operates in three segments: strategic, synergistic and non-core businesses. Strategic businesses comprise Retail Banking, Corporate Banking provided by Bank of Georgia as well as Asset and Wealth Management (AWM).

Description Quantum Pharma Plc is a United Kingdom-based manufacturer, supplier and service provider to pharmaceutical wholesalers, retail pharmacy, hospitals, pharmaceutical companies, and homecare and care home markets. The Company's business is the manufacture, procurement and supply to United Kingdom pharmacy chains, wholesalers and hospitals of specials and special obtains .The Company operates through five business units: Quantum Pharmaceutical, which manufactures and supplies specials and special obtains to the retail pharmacy chains in the United Kingdom; U L Medicines (ULM), is a supplier of unlicensed imports; Colonis, is a pharmaceutical product development business, which focuses on regulated status of medicines and medical devices; Biodose, consists of a tray, 28 medication pods and a seal, which is used to manage pre-prepared medication regimes for patients, and Quantum Aseptics, which prepares and supplies intravenous dosage form aseptic products.

this is much better .